Commented Articles

PanNASH covers commented articles ans publications to acquire sufficient information, understanding, and skills to cope with NASH/NAFLD healthcare demands.

Awareness related to NAFLD in Mexican-origin women

Mexican-origin women suffer disproportionate rates of NAFLD. The purpose of this study by K. E. Morrill et al. (University of Arizona Cancer Center, USA) was to assess awareness, knowledge, perceptions, and information sources related to NAFLD in a community-based sample of Mexican-origin women. Qualitative findings revealed low...
Read MoreAwareness related to NAFLD in Mexican-origin women

NAFLD and carotid Intima-media thickness in Nepal

The incidence of cardiovascular disease is higher in NAFLD as compared to those without NAFLD and studies have shown it being as a predictor of cardiovascular disease and independent of conventional risk factors. The objective of this descriptive cross-sectional study by B. Bc (7 Rapti Academy of Health Sciences, Dang, Nepal) was to find...
Read MoreNAFLD and carotid Intima-media thickness in Nepal

MAFLD: brain-gut-liver axis and insulin resistance

There are many complex physio-pathologic connections within the brain, gut, and liver axis. This review by E. Rebelos et al. (University of Turku, Finland) is focused on the early pathophysiology of brain, gut, and liver axis in the context of insulin resistance and specifically addresses two pillars of hepatic insulin resistance....

Read MoreMAFLD: brain-gut-liver axis and insulin resistance

Asia, Middle East, North Africa: burden of NAFLD

Using Global Burden of Disease data, P. Golabi et al. (Inova Health System, USA) aimed to assess the incidence, mortality, and disability-adjusted life years attributable to NAFLD-related liver complications in Asia, the Middle East and North Africa. As stated by the authors in their conclusion, “NAFLD is poised to contribute to a substantial...

Read MoreAsia, Middle East, North Africa: burden of NAFLD

FIB-4 and NFS: which performance?

M. Castellana et al. (National Institute of Gastroenterology "Saverio de Bellis," Research Hospital, Italy) conducted a meta-analysis to assess the performance of the FIB-4 and NFS scores, the 2 most common non-invasive tools, for the appropriate selection of subjects with AF for biopsy. A total of 18 studies evaluating 12,604 subjects were included...

Read MoreFIB-4 and NFS: which performance?

Enhanced liver fibrosis test and recognition of liver fibrosis

This retrospective cross-sectional study was conducted among patients recruited from a large, community-based hospital system's outpatient liver clinic from 2001 to 202 in order to determine the performance of the enhanced liver fibrosis (ELF) test as a non-invasive test for assessment of liver fibrosis among patients with NAFLD...

Read MoreEnhanced liver fibrosis test and recognition of liver fibrosis

NASH Epidemic: a call to action

NAFLD and NASH are common conditions with a rising burden. As pointed out by F. Kanwal et al. (Baylor College of Medicine, and Michael E. DeBakey Veterans Affairs Medical Center, Houston,USA), “yet there are significant management gaps between clinical guidelines and practice in patients with NAFLD and NASH. Further, there is no single...

Read MoreNASH Epidemic: a call to action

NAFLD and acute stroke: factors associated at admission

This retrospective study by T. Mori et al. (Shanghai Jiao Tong University School of Medicine, China) aimed to investigate NAFLD frequency and identify factors associated with NAFLD presence at acute stroke admission.

The authors included stroke patients admitted from 2016 to 2019, within 24 h of onset...

Read MoreNAFLD and acute stroke: factors associated at admission